Eiry Roberts Net Worth & Insider Trades
Eiry Roberts - Chief Medical Officer, Neurocrine Biosciences Inc
What is Eiry Roberts's Net Worth?
The current estimated net worth of Neurocrine Biosciences Inc's Chief Medical Officer, Eiry Roberts, is estimated to be about $7.86M . Eiry Roberts owns about 29,521 units of Neurocrine Biosciences Inc common stock. In the last 5 years at Neurocrine Biosciences Inc, Eiry Roberts has sold an estimated value of $6.69M worth.
What is Eiry Roberts's Past Insider Trading?
Eiry Roberts's largest purchase order was 5,000 units , worth over $389.05K on June 25, 2020. Eiry Roberts's largest sale order was 16,525 units , worth over $1.7M on February 8, 2023. In total, Eiry Roberts has made about 21 transactions over 5 years of their time at Neurocrine Biosciences Inc. Eiry Roberts usually trades in February, with the busiest year in 2020. The most recent transaction was a sale order of 3,198 units , worth over $343.39K on August 23, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EIRY ROBERTS
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Eiry Roberts's Salary in 2018?
As Chief Medical Officer of Neurocrine Biosciences Inc, Eiry Roberts has a total base salary of $490,700 . Eiry Roberts received compensation valued at about $8,300,623 in 2018 after becoming Chief Medical Officer. The vast majority of their compensation came in the form of a bonus of $220,800 , option awards of $2,863,700 , stock awards of $4,053,869 , and other compensation of $671,554 .
What is Eiry Roberts's' Mailing Address?
- Mailing address is C/o Neurocrine Biosciences, Inc. 12780 el Camino Real San Dieo CA 92130 CA
Neurocrine Biosciences Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Stock Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Kevin C. Gorman, Ph.D. | 2018 | $675,000 | $425,250 | $4,486,852 | $2,998,832 | $47,045 | $8,632,979 |
| Kevin C. Gorman, Ph.D. | 2019 | $725,000 | $667,000 | $6,000,525 | $2,000,071 | $58,230 | $9,450,826 |
| Kevin C. Gorman, Ph.D. | 2020 | $775,000 | $542,500 | $7,124,633 | $5,375,188 | $63,311 | $13,880,632 |
| Matthew C. Abernethy | 2018 | $420,000 | $199,500 | - | $1,996,506 | $69,741 | $2,685,747 |
| Matthew C. Abernethy | 2019 | $495,600 | $284,970 | $3,750,345 | $1,250,035 | $42,170 | $5,823,120 |
| Matthew C. Abernethy | 2020 | $545,200 | $190,820 | $2,999,869 | $2,500,266 | $45,021 | $6,281,176 |
| Eric Benevich | 2018 | $432,600 | $205,485 | $1,496,335 | $1,499,417 | $38,768 | $3,672,605 |
| Eric Benevich | 2019 | $467,200 | $280,320 | $3,750,345 | $1,250,035 | $45,547 | $5,793,447 |
| Eric Benevich | 2020 | $499,900 | $199,960 | $2,999,869 | $3,000,257 | $48,974 | $6,748,960 |
| Kyle W. Gano, Ph.D. | 2018 | $403,100 | $191,473 | $1,309,024 | $2,656,575 | $8,069 | $4,568,241 |
| Kyle W. Gano, Ph.D. | 2019 | $443,400 | $266,040 | $3,000,285 | $1,000,076 | $16,171 | $4,725,972 |
| Kyle W. Gano, Ph.D. | 2020 | $487,700 | $207,273 | $3,749,799 | $2,750,210 | $16,751 | $7,211,733 |
| Eiry W. Roberts, M.D. | 2018 | $490,700 | $220,800 | $2,863,700 | $4,053,869 | $671,554 | $8,300,623 |
| Eiry W. Roberts, M.D. | 2019 | $538,200 | $309,465 | $3,000,285 | $1,000,076 | $51,889 | $4,899,915 |
| Eiry W. Roberts, M.D. | 2020 | $575,900 | $215,963 | $2,624,855 | $2,375,242 | $56,073 | $5,848,033 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm
What are Neurocrine Biosciences Inc's Past Insider Trades?
Neurocrine Biosciences Inc's most recent insider trade came on September 14, 2023 by Gary Lyons who sold 5,000 units worth $575.12K . In the last 20 years, insiders at Neurocrine Biosciences Inc have sold an estimated value of $408.81M and bought an estimated value of $68.14M worth of shares. Insider trading is most common in February, with the busiest year in 2017. The most active traders at the company are Dimitri Grigoriadis, Chief Research Officer, Gary Lyons, Director, and Haig Bozigian, Chief Development Officer .
NEUROCRINE BIOSCIENCES INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||